Allurion Technologies (ALUR) Preferred Shares (2022 - 2023)
Allurion Technologies (ALUR) reported Preferred Shares of $2.8 million for Q4 2023, down 95.1% on a YoY basis from $58.0 million in Q4 2022, and up 84.31% quarter-over-quarter from $1.5 million in Q3 2023.
Allurion Technologies (ALUR) Preferred Shares (2022 - 2023) Analysis & Trends
Allurion Technologies has reported Preferred Shares for 2 years, with the latest figure at $2.8 million in Q4 2023.
- For the quarter ending Q4 2023, Preferred Shares fell 95.1% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2023 stood at $2.8 million (down 95.1% YoY), and the FY2023 full-year result was $2.8 million, down 95.1% from the prior year.
- Preferred Shares for Q4 2023 stood at $2.8 million, up from $1.5 million in the prior quarter.
- The five-year high for Preferred Shares was $58.0 million in Q2 2023, with the low at $1.5 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Allurion Technologies | - | - | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 58.03 Mn |
| Dec 31, 2022 | 58.00 Mn |